It means big pharma believes that NeuVax works and worth spending $12Millions upfront. Second possibility worth takeover.
Nobody tracks the "real numbers" but it estimated that one million people in the United States, per year, receive chemotherapy.
Chemotherapy is not just one thing..it simply refers to the chemical treatment (medication) of cancer. There are dozens of different drugs used on a wide variety of schedules, depending on the type of cancer being treated.
How Many People Get Chemo A Year?
I'm a chemo patient.
Estimated New Cases in 2014 ALONE is 1,665,540
Zuplenz contains ondansetron, which inhibits the neurotransmitter serotonin, thereby reducing nausea and vomiting. Galena says the oral thin strip version of the drug, administered via the top of the tongue, works better than the tablet formulation because it eliminates the burden of swallowing pills during episodes of vomiting, resulting in improved patient compliance
Galena investors of all stripes might have chosen to sell out and collect some profits after the stock's rise. That its executives did the same might be totally on the up-and-up. But in any case, the SEC is investigating Galena and its DreamTeam relationship, the company has said. As questions arose, the board launched its own investigation--and the company appointed a former SEC enforcement attorney to join those directors.
Not the sort of thing a company wants to announce in a press release (though it did disclose the probes to investors in an SEC filing). Now, Ahn's replacement, Mark Schwartz, has to manage the aftermath, step up marketing and sales for that newly licensed drug, Zuplenz, and keep that immunotherapy moving. Did we mention the lawsuits filed by shareholders--or Galena's own libel suit against the co-developer of its cancer vaccine? Meanwhile, Ahn himself says (as quoted by TheStreet) that he's "looking forward to the new adventure."
Dr. Schwartz served for five years as President and CEO of Bayhill Therapeutics, a company developing an innovative DNA vaccine platform for the treatment of autoimmune diseases where he completed a successful partnership with Genentech for the development of the company's Type 1 diabetes vaccine.
NO DUMPING BUT ITS SHORTING ...LOL
Some wasted interest after GALE but remember PHASE-3 anything can happen...
Roche's (RHHBY_) blockbuster cancer drug Herceptin works similarly, except it's not a vaccine but an antibody that attaches to HER2 receptors on breast cancer cells. In order for Herceptin to be effective, however, the breast cancer cells must overexpress HER2, meaning the cells need to have large numbers of HER2 receptors on their surface.
out rest for 17.90 Re: out half 16.90 keep rest for 18 if 17 breakRe: almost there from 16 alert Re...
Msg #1056 Thread #673662154 (Rec: 0)
13.2M shares short, longs don't need to do anything, just sit back and enjoy the ride back to $30